Pre-market Hot Trades in US Stocks

Ericsson is down 8.70% in pre-market trading. Based on recent key news:

1. On July 14, Ericsson announced its second-quarter financial report, with net sales of SEK 52.69 billion, lower than the market estimate of SEK 53.86 billion, leading to a drop in stock price. Source: Viewpoint Network

2. On July 14, Ericsson's Chief Financial Officer stated that chips and other components are facing price pressures, and a restructuring, including layoffs, is expected for the remainder of the year. Source: Viewpoint Network

3. On July 14, there were mixed ratings for Ericsson in the market, with 6 buy recommendations, 13 hold recommendations, and 8 sell recommendations from analysts, with an average target price of approximately SEK 101.52. Source: Viewpoint Network The telecommunications equipment industry is facing cost pressures and requires attention.

Trident Digital Tech is down 7.67% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Top Gainers in Pre-market US Stocks

Picard Medical is up 63.86% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Vision Marine Tech is up 53.24% in pre-market trading. Based on recent key news:

1. On July 13, Vision Marine Technologies released an important announcement on the EDGAR system, which may involve the company's future development direction, attracting market attention and driving a significant increase in stock price.

2. On July 9, HRT Financial sold all 34,746 shares of common stock it held in Vision Marine Technologies at a trading price of $1.25 per share, which may raise market concerns about changes in the company's shareholder structure.

3. Recently, Vision Marine Technologies has faced multiple challenges such as supply chain disruptions, tariffs, and trade policies. The company has disclosed related risks on EDGAR and SEDAR+, and investors should exercise caution. The impact of supply chain disruptions and trade policies is significant.

AEON Biopharma is up 43% in pre-market trading. AEON Biopharma has no significant news recently; the trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news